Cite
Ruppert AM, Beau-Faller M, Debieuvre D, et al. Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by . JTO Clin Res Rep. 2020;1(3):100052doi: 10.1016/j.jtocrr.2020.100052.
Ruppert, A. M., Beau-Faller, M., Debieuvre, D., Ouafik, L., Westeel, V., Rouquette, I., Mazières, J., Bringuier, P. P., Monnet, I., Escande, F., Ricordel, C., Merlio, J. P., Janicot, H., Lemoine, A., Foucher, P., Poudenx, M., Morin, F., Langlais, A., Souquet, P. J., Barlesi, F., & Wislez, M. (2020). Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by . JTO clinical and research reports, 1(3), 100052. https://doi.org/10.1016/j.jtocrr.2020.100052
Ruppert, Anne-Marie, et al. "Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by ." JTO clinical and research reports vol. 1,3 (2020): 100052. doi: https://doi.org/10.1016/j.jtocrr.2020.100052
Ruppert AM, Beau-Faller M, Debieuvre D, Ouafik L, Westeel V, Rouquette I, Mazières J, Bringuier PP, Monnet I, Escande F, Ricordel C, Merlio JP, Janicot H, Lemoine A, Foucher P, Poudenx M, Morin F, Langlais A, Souquet PJ, Barlesi F, Wislez M. Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by . JTO Clin Res Rep. 2020 May 15;1(3):100052. doi: 10.1016/j.jtocrr.2020.100052. eCollection 2020 Sep. PMID: 34589947; PMCID: PMC8474404.
Copy
Download .nbib